Delivery Order SPE2DB22D3009-SPE2DB24FBE48

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $16,624.60 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of 4,565,732,458 units of the pharmaceutical product CONCERTA ER 27 MG TABLET 100S. The contract has an ultimate completion date of September 10, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these essential prescription medications to support military treatment facilities and other federal healthcare providers nationwide....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,086.63 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,725,450 units of the drug Concerta ER 18 mg tablet. The contract has an ultimate completion date of September 10, 2024 and was awarded on September 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop...
The Defense Logistics Agency (DLA) awarded a $7,598.97 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division to provide 4,565,733,842 units of the medication CONCERTA ER 18 MG TABLET 100S. The contract has an ultimate completion date of September 10, 2024. This delivery order is part of a larger indefinite-delivery, indefinite-quantity (IDIQ) contract valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to...
This $10,384.68 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 100 units of CONCERTA ER 27 MG tablets, a prescription drug product. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a wide range of medical commodities to support military...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $16,311.83 to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,218,421 units of the prescription medication Concerta ER 54 mg tablets, with a completion date of July 23, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued up to $999,999,999 through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,242.46 to AmerisourceBergen Drug Corp for the delivery of 4,565,599,282 units of the medication Concerta ER 27 mg tablet. The contract has an ultimate completion date of August 28, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these essential prescription drugs to support U.S. government healthcare programs. This award is part of a larger Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $7,333.52 firm fixed-price contract is for the supply of 4565763778 CONCERTA ER 27 MG TABLET 100S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a...
The U.S. Defense Logistics Agency (DLA) awarded a $1,823.20 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565684012 CONCERTA ER 36 MG TABLET 100S. This contract has an ultimate completion date of September 5, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a $24,544.23 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,180,105 units of CONCERTA ER 18 MG TABLET 100S. The contract has an ultimate completion date of April 8, 2024 and was awarded on April 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that DLA Troop Support Medical awarded solely to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $5,356.20 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of CONCERTA ER 36 MG TABLET 100S, a branded pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB24FBE48
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $14,065.35 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,668,092 units of the prescription drug CONCERTA ER 27 MG TABLET. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is expected to be completed by September 4, 2024. Amerisourcebergen's extensive pharmaceutical and medical supply distribution capabilities enable it to efficiently fulfill critical drug and medical supply requirements for federal healthcare providers, including military treatment facilities and veterans' hospitals.

Generated 12/3/24, 10:05 AM